Literature DB >> 3670623

Magnetic resonance imaging of brain tumors: application of gadolinium-DTPA and comparison to computed tomography.

A L Agnoli1, D Jungmann, B Lochner.   

Abstract

In general, CT examinations still seem to be necessary for preoperative classification of brain masses. With increasing experience it should become clear whether sensitivity and specifity of MRI in the diagnosis of brain tumors can be further improved. Although much more work will be necessary in order to establish the optimal dose, timing, and pulse sequences when using Gd-DTPA, this study demonstrates that contrast changes due to Gd-DTPA can have clinical value.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670623     DOI: 10.1007/bf01780590

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  5 in total

1.  [Indications for magnetic resonance tomography in the diagnosis of cerebral diseases. Report of experiences with 1200 cases].

Authors:  W Schörner; J Treisch; R Felix; E Kazner
Journal:  Rofo       Date:  1986-02

2.  [Contrast in nuclear magnetic resonance imaging].

Authors:  W Semmler; R Felix
Journal:  Rofo       Date:  1984-09

3.  [Computed tomographic and nuclear spin tomographic diagnosis of brain tumors using conventional and paramagnetic contrast media].

Authors:  C Claussen; M Laniado; W Schörner; R Felix
Journal:  Rontgenblatter       Date:  1985-05

4.  Gadolinium-DTPA as a contrast agent in MR imaging--theoretical projections and practical observations.

Authors:  D G Gadian; J A Payne; D J Bryant; I R Young; D H Carr; G M Bydder
Journal:  J Comput Assist Tomogr       Date:  1985 Mar-Apr       Impact factor: 1.826

5.  Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex.

Authors:  R C Brasch; H J Weinmann; G E Wesbey
Journal:  AJR Am J Roentgenol       Date:  1984-03       Impact factor: 3.959

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.